Neuromuscular junction. History and present-day knowledge
Fardeau, M.; Dreyfus, P.
La Revue du Praticien 25(59): 4663-4667
1975
ISSN/ISBN: 0035-2640 PMID: 814609 Document Number: 91872
Document emailed within 1 workday
Related Documents
Takamori, M.; Sakato, S.; Matsubara, S.; Okumura, S. 1982: Function and structure of the neuromuscular junction Nihon Rinsho. Japanese Journal of Clinical Medicine 40(7): 1454-1458Giniatullin, R.A.; Sokolova, E.M. 1998: Modulating role of ATP in the neuromuscular junction Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 84(10): 1132-1138
Chauplannaz, G.; Vial, C. 2000: Electrodiagnosis of neuromuscular junction diseases Revue Neurologique (Paris) 156(1): 76-81
Pozaniakov, O.M.; Babakova, L.L.; Kolomenskaia, E.A.; Kuz'min, N.V. 1975: Ultrastructure of the neuromuscular junction in myasthenia Arkhiv Patologii 37(10): 55-63
Horvat-Znidarsic, I.; Suput, D.; Gubensek, F. 2000: The effect of ammodytin L on frog neuromuscular junction Pflugers Archiv: European Journal of Physiology 439(3 Suppl): R102-R103
Wilson, D.F.; Skirboll, L.R. 1974: Basis for posttetanic potentiation at the mammalian neuromuscular junction American Journal of Physiology 227(1): 92-95
Karcsú, S.; Tóth, L.; Katona, M. 1975: Electrocytochemical study of the neuromuscular junction in the process of ontogenesis Morphologiai Es Igazsagugyi Orvosi Szemle 15(2): 105-112
Madden, K.S.; Van der Kloot, W. 1985: Indomethacin, prostaglandin E2 and transmission at the frog neuromuscular junction Journal of Pharmacology and Experimental Therapeutics 232(2): 305-314
Hemsworth, B.A.; Cholakis, J.M. 1972: Mechanisms of action of a hemicholinium analogue at the neuromuscular junction Journal of Pharmacy and Pharmacology 24: Suppl: 147p
Hironaka, T. 1970: Effect of dimorpholamine (Th 1064) on crayfish neuromuscular junction Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 66(3): 293-303
Sellin, L.C.; Kauffman, J.A.; Dasgupta, B.R. 1983: Comparison of the effects of botulinum neurotoxin types a and e at the rat neuromuscular junction Medical Biology 61(2): 120-125
Nobe, S.; Kodama, K.; Suemori, I.; Yoshida, Y.; Adachi, H. 1971: Effects of some drugs on mobilization of transmitter substances in neuromuscular junction Masui. Japanese Journal of Anesthesiology 20(10): 937-938
Hudson, C.S.; Rash, J.E.; Tiedt, T.N.; Albuquerque, E.X. 1978: Neostigmine-induced alterations at the mammalian neuromuscular junction. II. Ultrastructure Journal of Pharmacology and Experimental Therapeutics 205(2): 340-356
Brumback, R.A. 1981: The neuromuscular junction. Part I: physiology and the effects of drugs and toxins American Family Physician 23(1): 188-192
Jurenić, D.; Jusić, A. 1978: Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication) Neurologija 26(1-4): 37-39
Zashikhin, A.L. 1989: Development and ultrastructure of the neuromuscular junction in bronchial smooth muscle tissue Arkhiv Anatomii Gistologii i Embriologii 97(7): 80-85
Audibert-Benoit, M.L. 1973: Effects of an intracellular injection of tetraethylammonium ion upon synaptic transmission in the neuromuscular junction of the frog Journal de Physiologie 67(3): 330a
Quik, M.; Collier, B.; Audhya, T.; Goldstein, G. 1990: Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junction Journal of Pharmacology and Experimental Therapeutics 254(3): 1113-1119
Babakova, L.L.; Krasnov, I.B.; Pozdniakov, O.M. 2008: Impact of 3-month simulation of the microgravity effects on the neuromuscular junction structure in rat's m. soleus Aviakosmicheskaia i Ekologicheskaia Meditsina 42(4): 31-35
Carmignani, M.; Scoppetta, C.; Ranelletti, F.O.; Tonali, P. 1984: Adverse interaction between acetazolamide and anticholinesterase drugs at the normal and myasthenic neuromuscular junction level International Journal of Clinical Pharmacology Therapy and Toxicology 22(3): 140-144